KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.